Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
42
SNNUF Quote, Financials, Valuation and Earnings
Last price:
$15.85
Seasonality move
:
-3.71%
Day range:
$15.85 - $15.85
52-week range:
$11.75 - $18.50
Dividend yield:
2.4%
P/E ratio:
28.41x
P/S ratio:
2.35x
P/B ratio:
3.35x
Volume:
--
Avg. volume:
932
1-year change:
29.71%
Market cap:
$13.5B
Revenue:
$5.8B
EPS (TTM):
$0.56
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Smith & Nephew plc has -- downside to fair value with a price target of -- per share.
SNNUF vs. S&P 500
-
Over the past 5 trading days, Smith & Nephew plc has overperformed the S&P 500 by 8.82% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Smith & Nephew plc does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Smith & Nephew plc has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Smith & Nephew plc reported revenues of --.
Earnings Growth
-
Smith & Nephew plc earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Smith & Nephew plc reported earnings per share of --.
Enterprise value:
15.2B
EV / Invested capital:
--
Price / LTM sales:
2.35x
EV / EBIT:
16.67x
EV / Revenue:
2.55x
PEG ratio (5yr expected):
0.23x
EV / Free cash flow:
19.01x
Price / Operating cash flow:
17.50x
Enterprise value / EBITDA:
9.75x
Gross Profit (TTM):
$4.2B
Return On Assets:
4.66%
Net Income Margin (TTM):
8.26%
Return On Equity:
9.2%
Return On Invested Capital:
5.7%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2013-12-31 | 2014-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $1.2B | $1.2B | |
| Gross Profit | -- | -- | -- | $882M | $940M | |
| Operating Income | -- | -- | -- | $307M | $372M | |
| EBITDA | -- | -- | -- | $332M | $353M | |
| Diluted EPS | -- | -- | -- | $0.18 | $0.18 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.4B | $3.8B | $3.9B | $4.5B | $4.6B | |
| Total Assets | $10.9B | $10.1B | $9.8B | $10.5B | $10.7B | |
| Current Liabilities | $2.1B | $2.1B | $1.8B | $1.8B | $1.5B | |
| Total Liabilities | $5.6B | $4.7B | $4.6B | $5.3B | $5.2B | |
| Total Equity | $5.3B | $5.4B | $5.2B | $5.2B | $5.5B | |
| Total Debt | $3.4B | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2013-12-31 | 2014-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $321M | $302M | |
| Cash From Investing | -- | -- | -- | -$199M | $85M | |
| Cash From Financing | -- | -- | -- | -$112M | -$426M | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
SNNUF
Sector
Market Cap
$13.5B
$27.9M
Price % of 52-Week High
85.68%
51.04%
Dividend Yield
2.4%
0%
Shareholder Yield
2.41%
-1.49%
1-Year Price Total Return
29.71%
-16.66%
Beta (5-Year)
0.338
0.516
Dividend yield:
2.4%
Annualized payout:
$0.61
Payout ratio:
-66.6%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$14.88
200-day SMA
Buy
Level
$15.60
Bollinger Bands (100)
Sell
Level
15.67 - 17.91
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$15.22
Relative Strength Index (RSI14)
Buy
Level
58.45
ADX Line
Buy
Level
13.78
Williams %R
Sell
Level
0
50-day SMA
Sell
Level
$16.20
MACD (12, 26)
Buy
Level
2.92
25-day Aroon Oscillator
Sell
Level
-52
On Balance Volume
Neutral
Level
160
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.2013)
Buy
CA Score
(Annual)
Level (0.2609)
Buy
Beneish M-Score
(Annual)
Level (-2.7631)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.3795)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Stock Forecast FAQ
In the current month, SNNUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SNNUF average analyst price target in the past 3 months is --.
-
Where Will Smith & Nephew plc Stock Be In 1 Year?
According to analysts, the consensus estimate is that Smith & Nephew plc share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Smith & Nephew plc?
Analysts are divided on their view about Smith & Nephew plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Smith & Nephew plc is a Sell and believe this share price will rise from its current level to --.
-
What Is Smith & Nephew plc's Price Target?
The price target for Smith & Nephew plc over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SNNUF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Smith & Nephew plc is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SNNUF?
You can purchase shares of Smith & Nephew plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Smith & Nephew plc shares.
-
What Is The Smith & Nephew plc Share Price Today?
Smith & Nephew plc was last trading at $15.85 per share. This represents the most recent stock quote for Smith & Nephew plc. Yesterday, Smith & Nephew plc closed at $15.85 per share.
-
How To Buy Smith & Nephew plc Stock Online?
In order to purchase Smith & Nephew plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SNNUF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SNNUF
Sector
P/E ratio
28.41x
23.85x
PEG ratio
0.23x
-0.01x
P/B ratio
3.35x
1.81x
Price / LTM sales
2.35x
1.58x
Growth Metrics
SNNUF
Sector
Revenue growth
--
4.62%
Earnings growth
--
10.5%
Revenue (5-year growth)
2.49%
6.5%
Earnings forecast
--
-$0.21
Profitability
SNNUF
Sector
Profitability FY 2024
$3.9B
$3.6M
Return on invested capital
5.7%
-31.87%
Return on assets
4.66%
-28.18%
Return on equity
9.2%
-37.63%
Earnings Date
Last Earnings Date
Aug
5
Next Earnings Date
Mar
2
Estimated Next Earnings Date
Nov
4
Balance Sheet
SNNUF
Sector
Total cash
$676M
$26.4M
Short term investments
--
$25.7M
Total assets
$10.4B
$76.9M
Long term debt
--
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
